{
    "id": 26988,
    "cites": 39,
    "cited_by": 0,
    "reference": [
        "Abouk, R., Moghtaderi, A., Helmchen, L. A., & Pines, J. (2019). Did the ACA Medicaid Expansions Fuel the Opioid Epidemic? Available at SSRN 3368434.",
        "Alpert, A. E., Evans, W. N., Lieber, E. M., & Powell, D. (2019). Origins of the Opioid Crisis and Its Enduring Impacts (No. w26500). National Bureau of Economic Research.",
        "Alpert, A., Powell, D., & Pacula, R. L. (2018). Supply-side drug policy in the presence of substitutes: Evidence from the introduction of abuse-deterrent opioids. American Economic Journal: Economic Policy, 10(4), 1-35.",
        "Bartholow, M. (2011). \u00c3\u00a2\u00e2\u0082\u00ac\u00c5\u0093Top 200 Drugs of 2010.\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u009d Pharmacy Times. May 16, 2011.",
        "Becker, W. C., & Fiellin, D. A. (2017). Abuse-deterrent opioid formulations\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dputting the potential benefits into perspective. New England Journal of Medicine, 376(22), 2103-2105.",
        "Beheshti, D. (2019). Adverse health effects of abuse\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u0090deterrent opioids: Evidence from the reformulation of OxyContin. Health Economics, 28(12), 1449-1461.",
        "Buchmueller, T. C., & Carey, C. (2018). The effect of prescription drug monitoring programs on opioid utilization in Medicare. American Economic Journal: Economic Policy, 10(1), 77-112.",
        "Ciani, E., & Fisher, P. (2018). Dif-in-dif estimators of multiplicative treatment effects. Journal of Econometric Methods, 8(1).",
        "Cicero, T. J., Ellis, M. S., & Surratt, H. L. (2012). Effect of abuse-deterrent formulation of OxyContin. New England Journal of Medicine, 367(2), 187-189.",
        "Cicero, T. J., & Ellis, M. S. (2015). Abuse-deterrent formulations and the prescription opioid abuse epidemic in the United States: lessons learned from OxyContin. JAMA Psychiatry, 72(5), 424-430.",
        "Cicero, T. J., Inciardi, J. A., & Mu\u00c3\u0083\u00c2\u00b1oz, A. (2005). Trends in abuse of OxyContin and other opioid analgesics in the United States: 2002-2004. The Journal of Pain, 6(10), 662-672.",
        "Coplan, P. M., Kale, H., Sandstrom, L., Landau, C., & Chilcoat, H. D. (2013). Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u0090release oxycodone with abuse\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u0090deterrent characteristics. Pharmacoepidemiology and Drug Safety, 22(12), 12741282.",
        "Dowell, D., Zhang, K., Noonan, R. K., & Hockenberry, J. M. (2016). Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates. Health Affairs, 35(10), 1876-1883.",
        "Evans, W. N., Lieber, E. M., & Power, P. (2019). How the reformulation of OxyContin ignited the heroin epidemic. Review of Economics and Statistics, 101(1), 1-15.",
        "Galenianos, M., Pacula, R. L., & Persico, N. (2012). A search-theoretic model of the retail market for illicit drugs. The Review of Economic Studies, 79(3), 1239-1269.",
        "Goodnough, A., & Zezima, K. (2011). An alarming new stimulant, legal in many states. The New York Times.",
        "Jacobson, M. (2004). Baby booms and drug busts: Trends in youth drug use in the United States, 1975\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2000. The Quarterly Journal of Economics, 119(4), 1481-1512.",
        "Jones, C.M., Baldwin, G. T., & Compton, W. M. (2017). Recent increases in cocaine-related overdose deaths and the role of opioids. American Journal of Public Health, 107(3), 430-432.",
        "Kariisa, M., Scholl, L., Wilson, N., Seth, P., & Hoots, B. (2019). Drug overdose deaths involving cocaine and psychostimulants with abuse potential\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dUnited States, 2003\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2017. Morbidity and Mortality Weekly Report, 68(17), 388.",
        "Kolodny, A., Courtwright, D. T., Hwang, C. S., Kreiner, P., Eadie, J. L., Clark, T. W., & Alexander, G. C. (2015). The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annual Review of Public Health, 36, 559-574.",
        "Maclean, J. C., & Saloner, B. (2019). The effect of public insurance expansions on substance use disorder treatment: evidence from the Affordable Care Act. Journal of Policy Analysis and Management, 38(2), 366-393.",
        "Mallatt, J. (2018). The effect of prescription drug monitoring programs on opioid prescriptions and heroin crime rates. Available at SSRN 3050692.",
        "Meinhofer, A. (2018). Prescription drug monitoring programs: The role of asymmetric information on drug availability and abuse. American Journal of Health Economics, 4(4), 504-526.",
        "Meinhofer, A., & Witman, A. E. (2018). The role of health insurance on treatment for opioid use disorders: Evidence from the Affordable Care Act Medicaid expansion. Journal of Health Economics, 60, 177-197.",
        "Miron, J. A. (2003). The effect of drug prohibition on drug prices: Evidence from the markets for cocaine and heroin. Review of Economics and Statistics, 85(3), 522-530.",
        "O\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2Donnell, J. K., Gladden, R. M., & Seth, P. (2017a). Trends in deaths involving heroin and synthetic opioids excluding methadone, and law enforcement drug product reports, by census region\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dUnited States, 2006\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2015. MMWR. Morbidity and Mortality Weekly Report, 66(34), 897.",
        "O\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0084\u00a2Donnell, J. K., Halpin, J., Mattson, C. L., Goldberger, B. A., & Gladden, R. M. (2017b). Deaths involving fentanyl, fentanyl analogs, and U-47700\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009d10 states, July\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009cDecember 2016. MMWR.",
        "Pardo, B. (2017). Do more robust prescription drug monitoring programs reduce prescription opioid overdose? Addiction, 112(10), 1773-1783.",
        "Pardo B, Caulkins JP, Kilmer B, Pacula RL Reuter P and BD Stein (2019). The Synthetic Opioid Surge in the United States: Insights from Mortality and Seizure Data. Santa Monica, CA: RAND Corporation 2019. https://www.rand.org/pubs/research_reports/RR3116.html.",
        "Patrick, S. W., Fry, C. E., Jones, T. F., & Buntin, M. B. (2016). Implementation of prescription drug monitoring programs associated with reductions in opioid-related death rates. Health Affairs, 35(7), 1324-1332.",
        "Popovici, I., Maclean, J. C., Hijazi, B., & Radakrishnan, S. (2018). The effect of state laws designed to prevent nonmedical prescription opioid use on overdose deaths and treatment. Health Economics, 27(2), 294-305.",
        "Powell, D., Alpert, A., & Pacula, R. L. (2019). A Transitioning Epidemic: How The Opioid Crisis Is Driving The Rise In Hepatitis C. Health Affairs, 38(2), 287-294.",
        "Powell, D., Pacula, R. L., & Jacobson, M. (2018). Do medical marijuana laws reduce addictions and deaths related to pain killers? Journal of Health Economics, 58, 29-42.",
        "Ruhm, C. J. (2018). Corrected US opioid\u00c3\u00a2\u00e2\u0082\u00ac\u00c2\u0090involved drug poisoning deaths and mortality rates, 1999\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c 2015. Addiction, 113(7), 1339-1344.",
        "Saloner, B., Akosa Antwi, Y., Maclean, J. C., & Cook, B. (2018). Access to health insurance and utilization of substance use disorder treatment: Evidence from the Affordable Care Act dependent coverage provision. Health Economics, 27(1), 50-75.",
        "Santos Silva, J., & Tenreyro, S. (2006). The log of gravity. The Review of Economics and Statistics, 88(4), 641-658.",
        "Scholl, L., Seth, P., Kariisa, M., Wilson, N., & Baldwin, G. (2019). Drug and opioid-involved overdose deaths\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009dUnited States, 2013\u00c3\u00a2\u00e2\u0082\u00ac\u00e2\u0080\u009c2017. Morbidity and Mortality Weekly Report, 67(5152), 1419.",
        "Swensen, I. D. (2015). Substance-abuse treatment and mortality. Journal of Public Economics, 122, 1330.",
        "Williams, J., Pacula, R. L., & Smart, R. (2019). De Facto or De Jure? Ethnic Differences in Quit Responses to Legal Protections of Medical Marijuana Dispensaries. National Bureau of Economic Research Working Paper Series # 25555."
    ]
}